Corporate news

21.11.2023
Marinomed Biotech AG: Stable revenues in the first three quarters of 2023 and further progress in business development
17.10.2023
Marinomed Biotech AG resumes Nice & Green Convertible Notes Funding Program with reduced volume
17.08.2023
Marinomed Biotech AG reports record revenues in the first half of the year and pushes business development activities
09.08.2023
Marinomed enters first long-term Solv4U partnership with Shanghai-based SPH Sine Pharmaceutical Laboratories Co. Ltd.
Lucia Ziegler, MSc
IR & PR Manager
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com